is now

Please update your bookmarks and favorites.
You will be taken to the new site in a few seconds.

Ten Research Projects from Miraca Life Sciences Accepted for ACG Conference

IRVING, Texas, August 10, 2016 — Ten research projects from the GI pathologists at Miraca Life Sciences, the nation’s largest independent anatomic pathology lab, have been accepted for presentation at the Annual Meeting of the American College of Gastroenterology (ACG), which will be held October 14–19 in Las Vegas.

Authors from Miraca Life Sciences are linked below to their profile on the company website.

One study has received the 2016 ACG Presidential Poster Award, given by the ACG Educational Affairs Committee to the most highly ranked abstract in each submission category:

  • “Duodenal Intraepithelial Lymphocytosis: A Condition with a Distinct Seasonal Incidence,” authors Robert M. Genta, Amnon Sonnenberg, Kevin Turner.

Two posters demonstrate the high clinical value of the company’s EoGenius RNA expression test for eosinophilic esophagitis:

  • “A Gene Expression Profile Test [EoGenius] Can Predict Subsequent Development of Histologic Eosinophilic Esophagitis in Patients with Non-diagnostic Index Biopsies,” authors Richard Lash, Ranjitha Veerappan, Robert M. Genta, Kimberly Schwanbeck.
  • “A Gene Expression Profile Test [EoGenius] for the Diagnosis of Eosinophilic Esophagitis Shows Excellent Correlation with Histological Findings of Esophageal Biopsies,” authors Danilo V. Tadeo, Jr., Bisher Abdullah, Jennifer Scudiere, Richard Lash, Robert M. Genta.

Seven additional studies from Miraca researchers will be presented at ACG:

About Miraca Life Sciences
Miraca Life Sciences provides proven high-quality anatomic pathology services, focusing on the fields of dermatology, hematology, gastroenterology, urology, and breast health. The company’s team of nearly 90 distinguished subspecialist pathologists utilizes state-of-the-art laboratories to serve more than 5,500 patients every day. Miraca Life Sciences’ difference is based on consensus-based medicine (including comprehensive sub-subspecialization, unified terminology and criteria, daily consensus conferences, extensive educational activities), rigorous quality assurance, active clinical research, innovation in testing, technological advancements, and health IT consulting services for clinician clients. Headquartered in Irving, Texas, Miraca Life Sciences is a subsidiary of Miraca Holdings Inc., one of Japan’s largest clinical diagnostics and laboratory testing service providers. For more information, visit

# # #

Media contact information:
Joy Jennings, Director of Marketing


See why Miraca Life Sciences' dermatopathology service is growing with consultations on biopsies from over 275,000 patients annually.

learn more


Explore why Miraca Life Sciences is the largest outpatient gastrointestinal pathology facility in the nation.

learn more


Learn how Miraca Life Sciences delivers the highest quality expertise in blood and bone marrow diagnostics.

learn more


Miraca Life Sciences Urologic Pathology Services

Discover how Miraca Life Sciences' urologic pathology experts focus on service and diagnostic excellence.

learn more